| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
SHB |
SHB: SH2 domain-containing adapter protein B |
33.250 |
Evidence |
O
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
FEN1 |
FEN1, RAD2: Flap endonuclease 1 |
32.960 |
Evidence |
O
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
CDK2 |
CDK2: Cell division protein kinase 2 |
32.910 |
Evidence |
O
|
| PDCD6IP |
PDCD6IP, AIP1, ALIX, KIAA1375: Programmed cell death 6-interacting protein |
CHMP4C |
CHMP4C, SHAX3: Charged multivesicular body protein 4c |
32.860 |
Evidence |
O
|
| PDCD6IP |
PDCD6IP, AIP1, ALIX, KIAA1375: Programmed cell death 6-interacting protein |
CHMP4B |
CHMP4B, C20orf178, SHAX1: Charged multivesicular body protein 4b |
32.860 |
Evidence |
O
|
| HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
EPS15 |
EPS15, AF1P: Epidermal growth factor receptor substrate 15 |
32.840 |
Evidence |
O
|
| KCNJ6 |
KCNJ6, GIRK2, KATP2, KCNJ7: G protein-activated inward rectifier potassium chann |
KCNJ9 |
KCNJ9, GIRK3: G protein-activated inward rectifier potassium channel 3 |
32.830 |
Evidence |
O
|
| SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
32.710 |
Evidence |
O
|
| SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
32.710 |
Evidence |
O
|
| SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
32.710 |
Evidence |
O
|
| POLR2D |
POLR2D: DNA-directed RNA polymerase II subunit RPB4 |
POLR2I |
POLR2I: DNA-directed RNA polymerase II subunit RPB9 |
32.230 |
Evidence |
O
|
| POLR2A |
POLR2A: Uncharacterized protein POLR2A |
POLR2I |
POLR2I: DNA-directed RNA polymerase II subunit RPB9 |
32.230 |
Evidence |
O
|
| POLR2E |
POLR2E: DNA-directed RNA polymerases I, II, and III subunit RPABC1 |
POLR2I |
POLR2I: DNA-directed RNA polymerase II subunit RPB9 |
32.230 |
Evidence |
O
|
| JUNB |
JUNB: Transcription factor jun-B |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
31.770 |
Evidence |
O
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
31.770 |
Evidence |
O
|
| CCNA2 |
CCNA2, CCN1, CCNA: Cyclin-A2 |
CDK2 |
CDK2: Cell division protein kinase 2 |
31.410 |
Evidence |
O
|
| JUN |
JUN: Transcription factor AP-1 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
31.240 |
Evidence |
O
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
CCNH |
CCNH: Cyclin-H |
31.240 |
Evidence |
O
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
31.240 |
Evidence |
O
|
| RB1 |
RB1: Retinoblastoma-associated protein |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
31.040 |
Evidence |
O
|
| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
ARHGDIA |
ARHGDIA, GDIA1: Rho GDP-dissociation inhibitor 1 |
31.000 |
Evidence |
O
|
| CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
30.910 |
Evidence |
O
|
| PSMD7 |
PSMD7, MOV34L: 26S proteasome non-ATPase regulatory subunit 7 |
PSMD11 |
PSMD11: 26S proteasome non-ATPase regulatory subunit 11 |
30.480 |
Evidence |
O
|
| PSMD3 |
PSMD3: 26S proteasome non-ATPase regulatory subunit 3 |
PSMD7 |
PSMD7, MOV34L: 26S proteasome non-ATPase regulatory subunit 7 |
30.480 |
Evidence |
O
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
30.080 |
Evidence |
O
|
